Verv is creating the first-of-its-kind consumer-oriented, affordable, high-quality blood chemistry analyser.
Verv Technologies has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in July 2022.
Verv Technologies's investors include National Research Council of Canada Industrial Research Assistance Program, Randox, Northern Ontario Heritage Fund, The Sudbury Catalyst Fund.
Verv Technologies is headquartered in Sudbury, Canada.
Verv is creating the first-of-its-kind consumer-oriented, affordable, high-quality blood chemistry analyser.
Verv Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Verv Technologies — Funding & Investors." VCBacked, July 21, 2022, https://www.vcbacked.co/company/verv-technologies. Accessed November 17, 2026.
VCBacked. (2022). Verv Technologies — Funding & Investors. Retrieved November 17, 2026, from https://www.vcbacked.co/company/verv-technologies
{{cite web |title=Verv Technologies — Funding & Investors |url=https://www.vcbacked.co/company/verv-technologies |website=VCBacked |access-date=November 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Verv Technologies? Request a listing update